Newsflash

Bio-Path Holdings Announces Dosing of First Patient in a Phase I Clinical Trial of Its Liposomal Grb-2 Cancer Drug Candidate

BUSINESS WIRE, July 29, 2010

Read more...

Activities

The latest issues of our newsletter here...

Appointments

08.07.2013
Beiratssitzung

16.09.2013
Phospholipid Symposium